New second-in-command for Dutch medicines agency
This article was originally published in SRA
Executive Summary
The Dutch Medicines Evaluation Board has appointed Stan van Belkum as its new deputy director in place of Rob de Haan, who has moved to a new role at the Health Care Inspectorate1.